December 17th 2020, 2:00pm
Older adults are often at greater risk for adverse events from treatments, but they can also be excluded from randomized controlled trials (RCTs), making it difficult to know if findings are generalizable to this population.
December 8th 2020, 11:00pm
This episode of Managed Care Cast is a preview of an interview with Michael E. Chernew, PhD, and A. Mark Fendrick, MD, the co-editors-in-chief of The American Journal of Managed Care®, which appears in the December issue of the journal.
December 5th 2020, 11:15pm
Researchers from the University of California San Francisco published their results in the Journal of Urology.
December 5th 2020, 5:15pm
In the real world, the persistence rate with secukinumab to treat psoriatic arthritis was higher than with ustekinumab.
November 20th 2020, 5:50pm
Results of the artificial intelligence (AI) model were consistent no matter which immune checkpoint inhibitor (ICI) therapy patients received, suggesting that some biomarkers are not necessarily specific to the checkpoint target.
November 20th 2020, 2:30pm
The mortality risk differs for the 3 endothelin receptor antagonists approved to treat pulmonary arterial hypertension (PAH) in elderly patients; however, a direct comparison in a controlled trial is still needed to confirm results.
November 7th 2020, 4:15pm
Understanding these genetic variants discovered through sequencing efforts is key to further progress in clinical genetics.
November 3rd 2020, 10:33pm
With the coronavirus disease 2019 pandemic, new research is quickly being released as more and more is learned. However, the flood of new research needs to be balanced with appropriate review before action is taken.
October 29th 2020, 9:45pm
Newer therapies have led to a boost in the number of patients with relapsed or refractory multiple myeloma (R/R MM) who are prescribed triplet regimens. As that shift has occurred, death rates appear to have dropped.
October 25th 2020, 6:45pm
The use of estimated glomerular filtration rate (eGFR) equations in assessing chronic kidney disease (CKD) for Black patients may lead to underdiagnosis and undertreatment, according to a nephrologist speaking at Kidney Week.
